VIJAY NAMBI

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    I01CX001112     (NAMBI, VIJAY)Oct 1, 2014 - Mar 31, 2020
    NIH
    Biomarker guided therapies in Stage A/B Heart Failure
    Role: Principal Investigator

    K23HL096893     (NAMBI, VIJAY)Sep 1, 2009 - May 31, 2013
    NIH
    Improving cardiovascular risk assessment using ultrasound imaging
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Venishetty N, Berry JD, de Lemos JA, Wu E, Lee MJ, Drawz PE, Nambi V, Ballantyne CM, Killeen AA, Ix JH, Shlipak MG, Ascher SB, Venishetty N, Berry JD, de Lemos JA, Wu E, Lee M, Drawz PE, Nambi V, Ballantyne CM, Killeen AA, Ix JH, Shlipak MG, Ascher SB. Associations of Ambulatory Blood Pressure Measurements With High-Sensitivity Troponin and Natriuretic Peptide Levels in SPRINT. Am J Hypertens. 2024 Jul 15; 37(8):571-579. PMID: 38554284; PMCID: PMC11247134.
      Citations:    Fields:    
    2. Deshotels MR, Kotta PA, Rico Mesa JS, Oyenubi OA, Nambi V. When Does Primary Prevention Encroach on Secondary Prevention? Curr Atheroscler Rep. 2024 Jul 08. PMID: 38976221.
      Citations:    Fields:    
    3. Haney D, Ma Y, Dalmacy D, Pajewski NM, Hajjar I, de Lemos JA, Zhang W, Soliman EZ, Ballantyne CM, Nambi V, Sattar N, Killeen AA, Ix JH, Shlipak MG, Berry JD, Ascher SB. High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT. Hypertension. 2024 Jul 03. PMID: 38957975.
      Citations:    Fields:    
    4. Mansoor T, Khalid SN, Bilal MI, Ijaz SH, Fudim M, Greene SJ, Warraich HJ, Nambi V, Virani SS, Fonarow GC, Abramov D, Minhas AMK. Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. Am J Cardiovasc Drugs. 2024 Jul; 24(4):481-504. PMID: 38907865.
      Citations:    Fields:    Translation:Humans
    5. Vigen R, Ayers C, Berry J, Rohatgi A, Nambi V, Ballantyne CM, Omland T, de Filippi CR, de Lemos J. Individual and Joint Associations of High-Sensitivity Troponin I and High-Sensitivity Troponin T with Cardiac Phenotypes and Outcomes in the General Population: An Analysis From the Dallas Heart Study. J Am Heart Assoc. 2024 Jul 02; 13(13):e034549. PMID: 38842289; PMCID: PMC11255706.
      Citations:    Fields:    Translation:Humans
    6. Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, Selvin E, Hoogeveen RC, Matsushita K, Nambi V, Yu B, Chen LY, Bick AG, Ebert BL, Honigberg MC, Li N, Shah A, Natarajan P, Kullo IJ, Ballantyne CM. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024 Jun 01; 9(6):497-506. PMID: 38598228; PMCID: PMC11007653.
      Citations:    Fields:    Translation:Humans
    7. Pandey A, Patel KV, Segar MW, Shapiro MD, Ballantyne CM, Virani SS, Nambi V, Michos ED, Blaha MJ, Nasir K, Cainzos-Achirica M, Ayers CR, Westenbrink BD, Flores-Guerrero JL, Bakker SJL, Connelly MA, Dullaart RPF, Rohatgi A. Association of High-Density Lipoprotein Parameters and Risk of Heart?Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul; 12(7):1242-1253. PMID: 38752934.
      Citations:    Fields:    Translation:Humans
    8. Garg M, Creechan P, Sadeghpour A, Abramov D, Dani SS, Ganatra S, Al-Kindi SG, Michos ED, Misra A, Deswal A, Palaskas NL, Virani SS, Nambi V, Minhas AMK. Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112. PMID: 38643926.
      Citations:    Fields:    Translation:Humans
    9. Ballantyne CM, Nambi V. HDL Therapeutics - Time for a Curtain Call or Time to Reconceptualize? N Engl J Med. 2024 May 02; 390(17):1622-1623. PMID: 38587250.
      Citations:    Fields:    Translation:Humans
    10. Minhas AMK, Mathew RO, Sperling LS, Nambi V, Virani SS, Navaneethan SD, Shapiro MD, Abramov D. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024 May 07; 83(18):1824-1826. PMID: 38583160.
      Citations:    Fields:    Translation:Humans
    11. Al Rifai M, Al-Mallah MH, Blaha MJ, Patel J, McEvoy JW, Nasir K, Shahid I, Patel KV, Sharma G, Marrugat J, Tizon-Marcos H, Erbel R, Stang A, J?ckel KH, Lehmann N, Schramm S, Schmidt B, Blumenthal RS, Virani SS, Nambi V, Cainzos-Achirica M. Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study. Diabetes Care. 2024 Apr 01; 47(4):698-706. PMID: 38329795.
      Citations:    Fields:    Translation:Humans
    12. Gupta K, Kakar TS, Merchant AT, Minhas AMK, Jain V, Shapiro MD, Abushamat LA, Nambi V, Virani SS. Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. Eur J Prev Cardiol. 2024 Mar 27; 31(5):e33-e35. PMID: 37619975.
      Citations:    Fields:    Translation:HumansPHPublic Health
    13. Smith C, Berry JD, Scherzer R, de Lemos JA, Nambi V, Ballantyne CM, Kravitz RL, Killeen AA, Ix JH, Shlipak MG, Ascher SB. Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT. J Am Heart Assoc. 2024 Mar 19; 13(6):e032493. PMID: 38497469; PMCID: PMC11010028.
      Citations:    Fields:    Translation:Humans
    14. Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE. Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2024 Mar 19; 13(6):e031607. PMID: 38471823; PMCID: PMC11010020.
      Citations:    Fields:    Translation:Humans
    15. Kotta PA, Nambi V, Misra A, Afshar H, Chelu MG, Nasir K, Abramov D, Minhas AMK. Association between neighborhood household income and inpatient atrial fibrillation outcomes. Heart Rhythm. 2024 Jul; 21(7):993-1000. PMID: 38382688.
      Citations:    Fields:    Translation:Humans
    16. Nambi V, Abushamat LA. LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon. J Am Coll Cardiol. 2024 02 13; 83(6):665-668. PMID: 38325991.
      Citations:    Fields:    Translation:Humans
    17. Minhas AMK, Talha KM, Abramov D, Johnson HM, Antoine S, Rodriguez F, Fudim M, Michos ED, Misra A, Abushamat L, Nambi V, Fonarow GC, Ballantyne CM, Virani SS. Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270. PMID: 38342731.
      Citations:    Fields:    
    18. Jia X, Nambi V, Berry JD, Dalmacy D, Ascher SB, Taylor AA, Hoogeveen RC, de Lemos JA, Ballantyne CM. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Chem. 2024 02 07; 70(2):414-424. PMID: 38084941.
      Citations:    Fields:    
    19. Talha KM, Waqar E, DiNino EK, Asghar A, Sperling LS, Sharafkhaneh A, Virani SS, Ballantyne CM, Nambi V, Minhas AMK. Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019. Curr Probl Cardiol. 2024 Feb; 49(2):102342. PMID: 38103816.
      Citations:    Fields:    Translation:Humans
    20. Khagi B, Belousova T, Short CM, Taylor A, Nambi V, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. A machine learning-based approach to identify peripheral artery disease using texture features from contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2024 Feb; 106:31-42. PMID: 38065273.
      Citations:    Fields:    Translation:Humans
    21. Kotta PA, Nambi V, Bozkurt B. Biomarkers for Heart Failure Prediction and Prevention. J Cardiovasc Dev Dis. 2023 Dec 06; 10(12). PMID: 38132656; PMCID: PMC10744096.
      Citations:    
    22. Minhas AMK, Parwani P, Fudim M, Virani SS, Khan SS, Cullen MW, Misra A, Ballantyne C, Nambi V, Abramov D. County-Level Cardiologist Density and Mortality in the United States. J Am Heart Assoc. 2023 12 05; 12(23):e031686. PMID: 38014694; PMCID: PMC10727342.
      Citations: 1     Fields:    Translation:Humans
    23. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Brunner G. Longitudinal Magnetic Resonance Imaging-Based Superficial Femoral Artery Velocity Measurements in Diabetic and Nondiabetic Patients With Peripheral Artery Disease. Top Magn Reson Imaging. 2023 Dec 01; 32(6):57-65. PMID: 38051028.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    24. Jia X, Buckley L, Sun C, Al Rifai M, Yu B, Nambi V, Virani SS, Selvin E, Matsushita K, Hoogeveen RC, Coresh J, Shah AM, Ballantyne CM. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740. PMID: 37306504; PMCID: PMC10637765.
      Citations: 1     Fields:    Translation:Humans
    25. Pajouheshnia R, Blaha MJ, Matsushita K, Nambi V, Klungel OH, Souverein PC, van der Schouw YT, Lehmann N, Erbel R, J?ckel KH, Hageman SHJ, Petitjaen C, Pennells L, Kaptoge S, Tillmann T, McClelland RL, Verschuren WMM, Di Angelantonio E, Visseren FLJ, Dorresteijn JAN. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. Eur J Prev Cardiol. 2023 10 26; 30(15):1705-1714. PMID: 37264679; PMCID: PMC10600319.
      Citations: 2     Fields:    Translation:Humans
    26. Kobo O, Mamas MA, Minhas AMK, Al-Kindi SG, Abushamat LA, Nambi V, Michos ED, Ballantyne C, Abramov D. Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States. Am J Med. 2024 Feb; 137(2):122-127.e1. PMID: 37879590.
      Citations:    Fields:    Translation:Humans
    27. Minhas AMK, Cullen MW, Mamas MA, Fudim M, Virani SS, Khan SS, Misra A, Ballantyne CM, Nambi V, Abramov D. Association Between Cardiologist Density and Mortality in Urban and Rural Counties in the United States. Am J Cardiol. 2024 01 01; 210:279-282. PMID: 37844717.
      Citations:    Fields:    
    28. Agha AM, Yu B, Hussain A, Nambi V, Chen LY, Matsushita K, Hoogeveen RC, Ballantyne CM, Shah AM, Buckley LF, Dorbala P, Claggett BL. MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study. Circ Heart Fail. 2023 11; 16(11):e010849. PMID: 37753653; PMCID: PMC10842537.
      Citations:    Fields:    Translation:Humans
    29. Al Rifai M, Jia X, Nambi V. Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure-Reply. JAMA Cardiol. 2023 09 01; 8(9):889-890. PMID: 37436758.
      Citations:    Fields:    Translation:Humans
    30. Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernab?-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, D?rr M, Donfrancesco C, Drygas W, Dullaart RP, Engstr?m G, Ferrario MM, Ferri?res J, de Gaetano G, Goldbourt U, Gonzalez C, Grassi G, Hodge AM, Hveem K, Iacoviello L, Ikram MK, Irazola V, Jobe M, Jousilahti P, Kaleebu P, Kavousi M, Kee F, Khalili D, Koenig W, Kontsevaya A, Kuulasmaa K, Lackner KJ, Leistner DM, Lind L, Linneberg A, Lorenz T, Lyngbakken MN, Malekzadeh R, Malyutina S, Mathiesen EB, Melander O, Metspalu A, Miranda JJ, Moitry M, Mugisha J, Nalini M, Nambi V, Ninomiya T, Oppermann K, d'Orsi E, Pajak A, Palmieri L, Panagiotakos D, Perianayagam A, Peters A, Poustchi H, Prentice AM, Prescott E, Ris?rus U, Salomaa V, Sans S, Sakata S, Sch?ttker B, Schutte AE, Sepanlou SG, Sharma SK, Shaw JE, Simons LA, S?derberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Twerenbold R, Vanuzzo D, Veronesi G, Waibel J, Wannamethee SG, Watanabe M, Wild PS, Yao Y, Zeng Y, Ziegler A, Blankenberg S. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023 10 05; 389(14):1273-1285. PMID: 37632466; PMCID: PMC10589462.
      Citations: 16     Fields:    Translation:Humans
    31. Al Rifai M, Taffet GE, Matsushita K, Virani SS, De Lemos J, Khera A, Berry J, Ndumele C, Aguilar D, Sun C, Hoogeveen RC, Selvin E, Ballantyne CM, Nambi V. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301. PMID: 37567021; PMCID: PMC10528351.
      Citations:    Fields:    Translation:Humans
    32. Minhas AMK, Fudim M, Garan AR, Davis JD, Fonarow GC, Antoine SM, Fedson S, Nambi V, Abramov D. Socioeconomic status and in-hospital outcomes for patients undergoing heart transplantation or ventricular assist device implantation. Clin Transplant. 2023 11; 37(11):e15093. PMID: 37548056.
      Citations:    Fields:    Translation:Humans
    33. Sharafkhaneh A, Agrawal R, Nambi V, BaHammam A, Razjouyan J. Obesity paradox or hypoxia preconditioning: How obstructive sleep apnea modifies the Obesity-MI relationship. Sleep Med. 2023 10; 110:132-136. PMID: 37574613; PMCID: PMC10529841.
      Citations: 1     Fields:    Translation:Humans
    34. Bebo A, Jarmul JA, Pletcher MJ, Hasbani NR, Couper D, Nambi V, Ballantyne CM, Fornage M, Morrison AC, Avery CL, de Vries PS. Coronary heart disease and ischemic stroke polygenic risk scores and atherosclerotic cardiovascular disease in a diverse, population-based cohort study. PLoS One. 2023; 18(6):e0285259. PMID: 37327218; PMCID: PMC10275447.
      Citations:    Fields:    Translation:Humans
    35. Kotta PA, Nambi V. Biomarker guided management of hypertension. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):427-433. PMID: 37382193.
      Citations: 1     Fields:    Translation:Humans
    36. Hussain A, Ramsey D, Lee M, Mahtta D, Khan MS, Nambi V, Ballantyne CM, Petersen LA, Walker AD, Kayani WT, Butler J, Slipczuk L, Rogers JG, Bozkurt B, Navaneethan SD, Virani SS. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942. PMID: 37204363.
      Citations: 3     Fields:    Translation:Humans
    37. Saadatagah S, Varughese MG, Nambi V. Coronary Artery Disease Risk Prediction in Young Adults: How Can We Overcome the Dominant Effect of Age? Curr Atheroscler Rep. 2023 06; 25(6):257-265. PMID: 37195598.
      Citations:    Fields:    Translation:Humans
    38. Abushamat LA, Nambi V. Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes. J Am Heart Assoc. 2023 05 16; 12(10):e029944. PMID: 37183835; PMCID: PMC10227283.
      Citations:    Fields:    Translation:Humans
    39. Wang MC, Petito LC, Pool LR, Foti K, Juraschek SP, McEvoy JW, Nambi V, Carnethon MR, Michos ED, Khan SS. The 2017 American College of Cardiology/American Heart Association Hypertension Guideline and Blood Pressure in Older Adults. Am J Prev Med. 2023 10; 65(4):640-648. PMID: 37105448; PMCID: PMC10524146.
      Citations:    Fields:    Translation:Humans
    40. Agrawal R, Sharafkhaneh A, Nambi V, BaHammam A, Razjouyan J. Obstructive sleep apnea modulates clinical outcomes post-acute myocardial infarction: A large longitudinal veterans' dataset report. Respir Med. 2023 05; 211:107214. PMID: 36924849; PMCID: PMC10122709.
      Citations: 1     Fields:    Translation:Humans
    41. Jia X, Al Rifai M, Hoogeveen R, Echouffo-Tcheugui JB, Shah AM, Ndumele CE, Virani SS, Bozkurt B, Selvin E, Ballantyne CM, Nambi V. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230. PMID: 36753229; PMCID: PMC9909572.
      Citations: 1     Fields:    Translation:Humans
    42. Jia X, Al Rifai M, Ndumele CE, Virani SS, de Lemos JA, Lee E, Shah AM, Echouffo-Tcheugui JB, Bozkurt B, Hoogeveen R, Selvin E, Ballantyne CM, Nambi V. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450. PMID: 36881398; PMCID: PMC10248756.
      Citations: 1     Fields:    Translation:Humans
    43. Gimnich OA, Belousova T, Short CM, Taylor AA, Nambi V, Morrisett JD, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. Magnetic Resonance Imaging-Derived Microvascular Perfusion Modeling to Assess Peripheral Artery Disease. J Am Heart Assoc. 2023 02 07; 12(3):e027649. PMID: 36688362; PMCID: PMC9973623.
      Citations:    Fields:    Translation:Humans
    44. Berry JD, Ascher SB, Shlipak MG, Ix JH, Gupta R, Killeen A, Toto RD, Ballantyne CM, de Lemos JA, Chen H, Nambi V, Ambrosius WT, Kitzman DW. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT. Circulation. 2023 Jan 24; 147(4):310-323. PMID: 36533535.
      Citations:    Fields:    Translation:Humans
    45. Walther CP, Benoit JS, Bansal N, Nambi V, Navaneethan SD, CRIC Study Investigators. Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 04; 81(4):446-456. PMID: 36403887; PMCID: PMC10038859.
      Citations:    Fields:    Translation:Humans
    46. Deshotels MR, Hadley TD, Roth M, Agha AM, Pulipati VP, Nugent AK, Virani SS, Nambi V, Moriarty PM, Davidson MH, Ballantyne CM. Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report. Arterioscler Thromb Vasc Biol. 2022 12; 42(12):1461-1467. PMID: 36325899.
      Citations: 1     Fields:    Translation:Humans
    47. Deshotels MR, Sun C, Nambi V, Virani SS, Matsushita K, Yu B, Ballantyne CM, Hoogeveen RC. Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 11; 11(21):e026762. PMID: 36285784; PMCID: PMC9673625.
      Citations:    Fields:    Translation:Humans
    48. Ascher SB, de Lemos JA, Lee M, Wu E, Soliman EZ, Neeland IJ, Kitzman DW, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Intensive Blood Pressure Lowering in?Patients With Malignant Left?Ventricular?Hypertrophy. J Am Coll Cardiol. 2022 10 18; 80(16):1516-1525. PMID: 36229087; PMCID: PMC9982833.
      Citations: 2     Fields:    Translation:Humans
    49. Hamo CE, Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg R, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne C, Selvin E, Coresh J, Ndumele CE. Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC). Clin Chem. 2022 10 06; 68(10):1272-1280. PMID: 35904048; PMCID: PMC9766881.
      Citations:    Fields:    
    50. Gupta K, Kakar TS, Jain V, Gupta M, Al Rifai M, Slipczuk L, Nambi V, Bittner V, Blumenthal RS, Stone NJ, Lavie CJ, Virani SS. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:78-82. PMID: 36038004.
      Citations:    
    51. Patel NA, Kianoush S, Jia X, Nambi V, Koh S, Patel J, Saeed A, Ahmed AI, Al-Mallah M, Agarwala A, Virani SS, Al Rifai M. Racial/Ethnic Disparities and Determinants of Sufficient Physical Activity Levels. Kans J Med. 2022; 15:267-272. PMID: 36042841; PMCID: PMC9409869.
      Citations:    
    52. Gimnich OA, Ortiz CB, Yang EY, Chen C, Virani SS, Kougias P, Lumsden AB, Morrisett JD, Ballantyne CM, Nambi V, Brunner G. Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus. Am J Cardiol. 2022 Oct 15; 181:130-138. PMID: 35999068.
      Citations:    
    53. Walther CP, Benoit JS, Gregg LP, Bansal N, Nambi V, Feldman HI, Shlipak MG, Navaneethan SD, CRIC Study Investigators. Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index. Int J Obes (Lond). 2022 10; 46(10):1910-1917. PMID: 35978101; PMCID: PMC9710200.
      Citations:    
    54. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Morrisett JD, Brunner G. Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease. Magn Reson Imaging. 2022 11; 93:128-134. PMID: 35940380.
      Citations:    
    55. Al Rifai M, Virani SS, Nambi V. Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention. J Am Heart Assoc. 2022 08 02; 11(15):e026600. PMID: 35876411; PMCID: PMC9375474.
      Citations:    Fields:    
    56. Charry D, Gouskova N, Meyer ML, Ring K, Nambi V, Heiss G, Tanaka H. Arterial stiffness and contralateral differences in blood pressure: The Atherosclerosis Risk in Communities (ARIC) study. J Clin Hypertens (Greenwich). 2022 07; 24(7):878-884. PMID: 35698928; PMCID: PMC9278590.
      Citations: 1     Fields:    Translation:Humans
    57. Kamat IS, Nazir S, Minhas AMK, Nambi V, Kulkarni P, Musher D, Bozkurt B, Plana JC, Jneid H. Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction. Am J Cardiol. 2022 07 01; 174:27-33. PMID: 35523592.
      Citations:    Fields:    Translation:Humans
    58. Florido R, Kwak L, Echouffo-Tcheugui JB, Zhang S, Michos ED, Nambi V, Goldberg RB, Hoogeveen RC, Lazo M, Gerstenblith G, Post WS, Blumenthal RS, Coresh J, Folsom AR, Selvin E, Ballantyne C, Ndumele CE. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2022 05 03; 11(9):e023238. PMID: 35491999; PMCID: PMC9238585.
      Citations:    Fields:    Translation:Humans
    59. Jia X, Sun C, Nambi V, Virani SS, Taffet G, Boerwinkle E, Bressler J, Ndumele C, Windham BG, de Lemos JA, Matsushita K, McEvoy JW, Hoogeveen RC, Selvin E, Ballantyne CM. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89. PMID: 35550933; PMCID: PMC9627572.
      Citations:    Fields:    Translation:Humans
    60. Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM, Hoogeveen RC. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol. 2022 03 11; 29(2):e53-e64. PMID: 33580780; PMCID: PMC8277878.
      Citations: 2     Fields:    Translation:Humans
    61. Ascher SB, Scherzer R, de Lemos JA, Estrella MM, Jotwani VK, Garimella PS, Bullen AL, Ambrosius WT, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT. J Am Heart Assoc. 2022 03 15; 11(6):e023314. PMID: 35243872; PMCID: PMC9075292.
      Citations:    Fields:    Translation:Humans
    62. Hamo CE, Kwak L, Wang D, Florido R, Echouffo-Tcheugui JB, Blumenthal RS, Loehr L, Matsushita K, Nambi V, Ballantyne CM, Selvin E, Folsom AR, Heiss G, Coresh J, Ndumele CE. Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. J Am Heart Assoc. 2022 02 15; 11(4):e021583. PMID: 35156388; PMCID: PMC9245814.
      Citations:    Fields:    Translation:Humans
    63. Johri AM, Nambi V, Sillesen H. Response to Azarpazhooh et?al., Reliability, Reproducibility and Advantages of Measuring Carotid Total Plaque Area. J Am Soc Echocardiogr. 2022 05; 35(5):532. PMID: 35134520.
      Citations:    Fields:    Translation:Humans
    64. Al Rifai M, Blaha MJ, Nambi V, Shea SJC, Michos ED, Blumenthal RS, Ballantyne CM, Szklo M, Greenland P, Miedema MD, Nasir K, Rotter JI, Guo X, Yao J, Post WS, Virani SS. Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 01 25; 145(4):259-267. PMID: 34879218; PMCID: PMC8792296.
      Citations: 3     Fields:    Translation:Humans
    65. Berry JD, Nambi V, Ambrosius WT, Chen H, Killeen AA, Taylor A, Toto RD, Soliman EZ, McEvoy JW, Pandey A, Joshi PH, Blankenberg S, Kitzman DW, Ballantyne CM, de Lemos JA. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial. JAMA Cardiol. 2021 12 01; 6(12):1397-1405. PMID: 34468696; PMCID: PMC8411355.
      Citations: 1     Fields:    Translation:Humans
    66. Krittanawong C, Khawaja M, Rosenson RS, Amos CI, Nambi V, Lavie CJ, Virani SS. Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy. Curr Probl Cardiol. 2022 Jul; 47(7):101043. PMID: 34780866.
      Citations: 2     Fields:    Translation:Humans
    67. Jia X, Lee MT, Ramsey DJ, Mahtta D, Akeroyd JM, Turchin A, Navar AM, Matheny ME, Gobbel G, Stone NJ, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839. PMID: 34666951.
      Citations:    Fields:    Translation:Humans
    68. Pickett SJ, Levine GN, Jneid H, Bhatt DL, Nambi V. Is There an Optimal Antiplatelet Strategy after Gastrointestinal Bleeding in Patients with Coronary Artery Disease? Cardiology. 2021; 146(6):668-677. PMID: 34521081.
      Citations:    Fields:    Translation:Humans
    69. Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SS. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6. PMID: 34371083.
      Citations:    Fields:    Translation:HumansPHPublic Health
    70. Jia X, Sun C, Tanaka H, Al Rifai M, Aguilar D, Ndumele C, Selvin E, Virani SS, Hoogeveen RC, Heiss G, Ballantyne CM, Nambi V. Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa. 2021 Nov; 50(6):439-445. PMID: 34346252; PMCID: PMC8620155.
      Citations:    Fields:    Translation:Humans
    71. Echouffo-Tcheugui JB, Zhang S, Florido R, Hamo C, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE. Duration of Diabetes and Incident?Heart?Failure: The ARIC (Atherosclerosis Risk In Communities) Study. JACC Heart Fail. 2021 08; 9(8):594-603. PMID: 34325890; PMCID: PMC8629143.
      Citations: 4     Fields:    Translation:Humans
    72. Bansal N, Zelnick LR, Ballantyne CM, Chaves PHM, Christenson RH, Coresh J, deFilippi CR, de Lemos JA, Daniels LB, Go AS, He J, Hedayati SS, Matsushita K, Nambi V, Shlipak MG, Taliercio JJ, Seliger SL, CRIC Study Investigators. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD. Am J Kidney Dis. 2022 Mar; 79(3):383-392. PMID: 34293394; PMCID: PMC8766621.
      Citations: 1     Fields:    Translation:Humans
    73. Agha AM, Jones PH, Ballantyne CM, Virani SS, Nambi V. Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). J Clin Lipidol. 2021 Sep-Oct; 15(5):649-652. PMID: 34393074.
      Citations: 2     Fields:    Translation:Humans
    74. Ballantyne CM, Nambi V. Statins and Your Memory: "Forget" About It? J Am Coll Cardiol. 2021 06 29; 77(25):3157-3159. PMID: 34167640; PMCID: PMC9090519.
      Citations:    Fields:    Translation:Humans
    75. Jia X, Gao F, Pickett JK, Al Rifai M, Birnbaum Y, Nambi V, Virani SS, Ballantyne CM. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800. PMID: 34057665.
      Citations:    Fields:    Translation:Humans
    76. Virani SS, Nambi V, Ballantyne CM. Has the 'strength' of fish oil therapy been 'reduced'? Reconciling the results of REDUCE-IT and STRENGTH. Eur Heart J Cardiovasc Pharmacother. 2021 05 23; 7(3):e7-e8. PMID: 33537734.
      Citations:    Fields:    Translation:Humans
    77. Commodore-Mensah Y, Lazo M, Tang O, Echouffo-Tcheugui JB, Ndumele CE, Nambi V, Wang D, Ballantyne C, Selvin E. High Burden of Subclinical and Cardiovascular Disease Risk in Adults With Metabolically Healthy Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2021 07; 44(7):1657-1663. PMID: 33952606; PMCID: PMC8323178.
      Citations: 6     Fields:    Translation:Humans
    78. Navaneethan SD, Walther CP, Gregg LP, Bansal S, Winkelmayer WC, Nambi V, Niu J. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1. PMID: 33905766; PMCID: PMC8542055.
      Citations: 1     Fields:    Translation:Humans
    79. Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA. 2021 Apr 20; 325(15):1545-1555. PMID: 33877270.
      Citations: 9     Fields:    Translation:Humans
    80. Elbadawi A, Elgendy IY, Omer M, Abdelazeem M, Nambi V, Krittanawong C, Hira RS, Tamis-Holland J, Ballantyne C, Jneid H. Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia. Am J Med. 2021 08; 134(8):992-1001.e4. PMID: 33872584.
      Citations:    Fields:    Translation:Humans
    81. Segar MW, Jaeger BC, Patel KV, Nambi V, Ndumele CE, Correa A, Butler J, Chandra A, Ayers C, Rao S, Lewis AA, Raffield LM, Rodriguez CJ, Michos ED, Ballantyne CM, Hall ME, Mentz RJ, de Lemos JA, Pandey A. Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis. Circulation. 2021 06 15; 143(24):2370-2383. PMID: 33845593; PMCID: PMC9976274.
      Citations: 9     Fields:    Translation:Humans
    82. Nambi V, Agha A. Inclisiran: A Game Changer in a Changing Game? J Am Coll Cardiol. 2021 03 09; 77(9):1194-1196. PMID: 33663736.
      Citations: 2     Fields:    Translation:Humans
    83. Barnouin Y, Armamento-Villareal R, Celli A, Jiang B, Paudyal A, Nambi V, Bryant MS, Marcelli M, Garcia JM, Qualls C, Villareal DT. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1096-e1110. PMID: 33351921.
      Citations: 6     Fields:    Translation:Humans
    84. Hussain A, Sun W, Deswal A, de Lemos JA, McEvoy JW, Hoogeveen RC, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumule C, Ballantyne CM, Nambi V. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571. PMID: 33538254; PMCID: PMC7945981.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    85. Hussain A, Tang O, Sun C, Jia X, Selvin E, Nambi V, Folsom A, Heiss G, Mosley T, Virani SS, Coresh J, Boerwinkle E, Yu B, Cunningham JW, Shah AM, Solomon SD, de Lemos JA, Hoogeveen RC, Ballantyne CM, Zannad F. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21. PMID: 33539861; PMCID: PMC8038970.
      Citations: 4     Fields:    Translation:Humans
    86. Brunner G, Virani SS, Sun W, Liu L, Dodge RC, Nambi V, Coresh J, Mosley TH, Sharrett AR, Boerwinkle E, Ballantyne CM, Wasserman BA. Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study. JAMA Cardiol. 2021 01 01; 6(1):79-86. PMID: 33206125; PMCID: PMC7675218.
      Citations: 6     Fields:    Translation:Humans
    87. Biswas M, Jamthikar AD, Saba L, Faa G, Oberleitner R, Turk M, Srivastava S, Suri HS, Johri AM, Nambi V, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Bit A, Pareek G, Miner M, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji J, Porcu M, Al-Maini M, Agbakoba A, Sockalingam M, Sexena A, Nicolaides A, Sharma A, Rathore V, Viswanathan V, Naidu S, Bhatt DL, Suri JS, Puvvula A, Majhail M, Singh IM, Chadha PS. Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence. Rev Cardiovasc Med. 2020 12 30; 21(4):541-560. PMID: 33387999.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    88. Al Rifai M, Mirbolouk M, Jia X, Nasir K, Pickett JK, Nambi V, Ballantyne CM, Merchant AT, Blaha MJ, Virani SS. E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey. Kans J Med. 2020; 13:318-321. PMID: 33343826; PMCID: PMC7735432.
      Citations: 4     
    89. Jia X, Sun C, Tang O, Gorlov I, Nambi V, Virani SS, Villareal DT, Taffet GE, Yu B, Bressler J, Boerwinkle E, Windham BG, de Lemos JA, Matsushita K, Selvin E, Michos ED, Hoogeveen RC, Ballantyne CM. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12). PMID: 32785663; PMCID: PMC7526732.
      Citations: 5     Fields:    Translation:Humans
    90. Jamthikar AD, Puvvula A, Gupta D, Johri AM, Nambi V, Khanna NN, Saba L, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Nicolaides A, Sharma AM, Viswanathan V, Rathore VS, Kolluri R, Bhatt DL, Suri JS. Cardiovascular disease and stroke risk assessment in patients with chronic kidney disease using integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence: a narrative review. Int Angiol. 2021 Apr; 40(2):150-164. PMID: 33236868.
      Citations: 6     Fields:    Translation:Humans
    91. Gimnich OA, Holbrook J, Belousova T, Short CM, Taylor AA, Nambi V, Morrisett JD, Ballantyne CM, Bismuth J, Shah DJ, Brunner G. Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease. Am J Cardiol. 2021 02 01; 140:140-147. PMID: 33144163; PMCID: PMC8210786.
      Citations:    Fields:    Translation:Humans
    92. Khera R, Pandey A, Ayers CR, Carnethon MR, Greenland P, Ndumele CE, Nambi V, Seliger SL, Chaves PHM, Safford MM, Cushman M, Xanthakis V, Vasan RS, Mentz RJ, Correa A, Lloyd-Jones DM, Berry JD, de Lemos JA, Neeland IJ. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index. JAMA Netw Open. 2020 10 01; 3(10):e2023242. PMID: 33119108; PMCID: PMC7596579.
      Citations: 6     Fields:    Translation:Humans
    93. Suzuki T, Wang W, Wilsdon A, Butler KR, Adabag S, Griswold ME, Nambi V, Rosamond W, Sotoodehnia N, Mosley TH. Carotid Intima-Media Thickness and the Risk of Sudden Cardiac Death: The ARIC Study and the CHS. J Am Heart Assoc. 2020 10 20; 9(19):e016981. PMID: 32975158; PMCID: PMC7792412.
      Citations: 6     Fields:    Translation:Humans
    94. Al Rifai M, Merchant AT, Nambi V, Jia X, Gulati M, Mahtta D, Nasir K, Ballantyne CM, Virani SS. Letter to the Editor: Temporal Trends in E-Cigarette and Cigarette Use Among US Adults by US State: Behavioral Risk Factor Surveillance System, 2016 to 2018. Popul Health Manag. 2021 06; 24(3):414-415. PMID: 32941106.
      Citations:    Fields:    Translation:Humans
    95. Hussain A, Ballantyne CM, Nambi V. Zero Coronary Artery Calcium Score: Desirable, but Enough? Circulation. 2020 09 08; 142(10):917-919. PMID: 32897743.
      Citations: 5     Fields:    Translation:Humans
    96. Gore MO, Ayers CR, Khera A, deFilippi CR, Wang TJ, Seliger SL, Nambi V, Selvin E, Berry JD, Hundley WG, Budoff M, Greenland P, Drazner MH, Ballantyne CM, Levine BD, de Lemos JA. Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults. J Am Heart Assoc. 2020 08 04; 9(15):e015410. PMID: 32698652; PMCID: PMC7792258.
      Citations: 4     Fields:    Translation:Humans
    97. Ding N, Yang C, Ballew SH, Kalbaugh CA, McEvoy JW, Salameh M, Aguilar D, Hoogeveen RC, Nambi V, Selvin E, Folsom AR, Heiss G, Coresh J, Ballantyne CM, Matsushita K. Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study. Arterioscler Thromb Vasc Biol. 2020 09; 40(9):2322-2331. PMID: 32698688; PMCID: PMC7678951.
      Citations: 11     Fields:    Translation:Humans
    98. Johri AM, Nambi V, Naqvi TZ, Feinstein SB, Kim ESH, Park MM, Becher H, Sillesen H. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020 08; 33(8):917-933. PMID: 32600741.
      Citations: 23     Fields:    Translation:Humans
    99. Aguilar D, Sun C, Hoogeveen RC, Nambi V, Selvin E, Matsushita K, Saeed A, McEvoy JW, Shah AM, Solomon SD, Boerwinkle E, Ballantyne CM. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study. J Am Heart Assoc. 2020 07 07; 9(13):e015405. PMID: 32573308; PMCID: PMC7670497.
      Citations: 5     Fields:    Translation:HumansCells
    100. Pickett JK, Shah M, Gillette M, Jones P, Virani S, Ballantyne C, Nambi V. Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor. JACC Case Rep. 2020 Jun 17; 2(7):1042-1045. PMID: 34317411; PMCID: PMC8302111.
      Citations: 1     
    101. Mandviwala TM, Basra SS, Khalid U, Pickett JK, Przybylowicz R, Shah T, Nambi V, Virani SS, Deswal A. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567. PMID: 32483205.
      Citations: 2     Fields:    Translation:Humans
    102. Nambi V, Hussain A, Stein JH. Safety of Evolocumab in People Living With HIV Infection: An Important First Step. J Am Coll Cardiol. 2020 05 26; 75(20):2585-2587. PMID: 32439007.
      Citations:    Fields:    Translation:Humans
    103. Florido R, Kwak L, Lazo M, Michos ED, Nambi V, Blumenthal RS, Gerstenblith G, Palta P, Russell SD, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE. Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. J Am Heart Assoc. 2020 05 18; 9(10):e014885. PMID: 32390492; PMCID: PMC7660876.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    104. Hussain A, Johri AM, Misra A, Nambi V. "Sound" Advice-Let's "Stress" the Importance of Prevention: Combining Carotid Ultrasound and Stress Echocardiography for Cardiovascular Risk Assessment. J Am Soc Echocardiogr. 2020 05; 33(5):570-572. PMID: 32362333.
      Citations:    Fields:    Translation:Humans
    105. Al Rifai M, Merchant AT, Nambi V, Jia X, Gulati M, Valero-Elizondo J, Nasir K, Ballantyne CM, Virani SS. Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. Am J Med. 2020 09; 133(9):e508-e511. PMID: 32222250.
      Citations: 7     Fields:    Translation:Humans
    106. Walther CP, Nambi V, Hanania NA, Navaneethan SD. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945. PMID: 32199709; PMCID: PMC7247937.
      Citations: 6     Fields:    Translation:Humans
    107. Jaspers NEM, Blaha MJ, Matsushita K, van der Schouw YT, Wareham NJ, Khaw KT, van der Graaf Y, Verschuren WMM, Boer JMA, Nambi V, Visseren FLJ, Dorresteijn JAN, Geisel MH, Lehmann N, Erbel R, J?ckel KH. Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. Eur Heart J. 2020 03 14; 41(11):1190-1199. PMID: 31102402; PMCID: PMC7229871.
      Citations: 22     Fields:    Translation:Humans
    108. Meyer ML, Klein BE, Klein R, Palta P, Sharrett AR, Heiss G, Nambi V, Wong TY, Tanaka H. Central arterial stiffness and retinal vessel calibers: the Atherosclerosis Risk in Communities Study-Neurocognitive Study. J Hypertens. 2020 02; 38(2):266-273. PMID: 31584520; PMCID: PMC6949400.
      Citations: 4     Fields:    Translation:Humans
    109. Nambi V, Sikand G, Kalra D, Vijayaraghavan K. Low-density lipoprotein cholesterol goals in the secondary prevention of cardiovascular diseases in the Indian population-Is 30 the new 70? J Clin Lipidol. 2020 Mar - Apr; 14(2):173-175. PMID: 32098725.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    110. Lewis AA, Ayers CR, Selvin E, Neeland I, Ballantyne CM, Nambi V, Pandey A, Powell-Wiley TM, Drazner MH, Carnethon MR, Berry JD, Seliger SL, DeFilippi CR, de Lemos JA. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study. Circulation. 2020 03 24; 141(12):957-967. PMID: 31931608; PMCID: PMC7093253.
      Citations: 10     Fields:    Translation:Humans
    111. Yang EY, Khan MA, Graviss EA, Nguyen DT, Bhimaraj A, Nambi V, Hoogeveen RC, Ballantyne CM, Zoghbi WA, Shah DJ. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019 12 27; 9(1):20168. PMID: 31882822; PMCID: PMC6934524.
      Citations: 2     Fields:    Translation:HumansCells
    112. Jia X, Ramsey DJ, Rifai MA, Ahmed ST, Akeroyd JM, Dixon DL, Gluckman TJ, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879. PMID: 31952841.
      Citations: 1     Fields:    Translation:Humans
    113. Yang EY, Ghosn MG, Khan MA, Gramze NL, Brunner G, Nabi F, Nambi V, Nagueh SF, Nguyen DT, Graviss EA, Schelbert EB, Ballantyne CM, Zoghbi WA, Shah DJ. Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis. Circ Cardiovasc Imaging. 2019 12; 12(12):e009535. PMID: 31838882; PMCID: PMC7529265.
      Citations: 13     Fields:    Translation:HumansCells
    114. Pandey A, Patel KV, Vongpatanasin W, Ayers C, Berry JD, Mentz RJ, Blaha MJ, McEvoy JW, Muntner P, Vaduganathan M, Correa A, Butler J, Shimbo D, Nambi V, deFilippi C, Seliger SL, Ballantyne CM, Selvin E, de Lemos JA, Joshi PH. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis. Circulation. 2019 12 17; 140(25):2076-2088. PMID: 31707797; PMCID: PMC8330617.
      Citations: 11     Fields:    Translation:Humans
    115. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM. Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study". Circulation. 2019 11 12; 140(20):e772-e773. PMID: 31710526; PMCID: PMC7202330.
      Citations: 1     Fields:    Translation:Humans
    116. Nambi V, Virani SS, Jones PH, Ballantyne CM. "Zero": The New Superhero or Superhero in Training? J Am Coll Cardiol. 2019 11 05; 74(18):2331. PMID: 31672196.
      Citations:    Fields:    Translation:Humans
    117. Aguilar D, Nambi V. Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes. Diabetes Care. 2019 11; 42(11):2019-2021. PMID: 31636148.
      Citations: 1     Fields:    Translation:Humans
    118. Howard CE, Nambi V, Jneid H, Khalid U. Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long? J Am Heart Assoc. 2019 10 15; 8(20):e012639. PMID: 31576769; PMCID: PMC6818039.
      Citations: 4     Fields:    Translation:Humans
    119. Tehrani DM, Fan W, Nambi V, Gardin J, Hirsch CH, Amsterdam E, deFilippi CR, Polonsky T, Wong ND. Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study. Am J Hypertens. 2019 09 24; 32(10):1013-1020. PMID: 31232455; PMCID: PMC6758940.
      Citations: 1     Fields:    Translation:Humans
    120. Pokharel Y, Mouhanna F, Schneider ALC, Rawlings AM, Knopman DS, Nambi V, Virani SS, Hoogeveen RC, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman R, Selvin E, Ballantyne C, Power MC. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. J Am Geriatr Soc. 2019 11; 67(11):2353-2361. PMID: 31359423; PMCID: PMC6861618.
      Citations: 2     Fields:    Translation:Humans
    121. Ballantyne CM, Nambi V. Seven Metrics That Will Determine Your Cardiovascular Success or Failure. JACC Heart Fail. 2019 08; 7(8):648-650. PMID: 31302041.
      Citations:    Fields:    Translation:Humans
    122. Jia X, Al Rifai M, Ramsey DJ, Ahmed ST, Akeroyd JM, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. Am J Med. 2019 09; 132(9):e693-e700. PMID: 31103643.
      Citations: 3     Fields:    Translation:Humans
    123. Wang Z, Zhu C, Nambi V, Morrison AC, Folsom AR, Ballantyne CM, Boerwinkle E, Yu B. Metabolomic Pattern Predicts Incident Coronary Heart Disease. Arterioscler Thromb Vasc Biol. 2019 07; 39(7):1475-1482. PMID: 31092011; PMCID: PMC6839698.
      Citations: 17     Fields:    Translation:Humans
    124. Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MC. ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology. 2019 05 28; 92(22):e2580-e2593. PMID: 31043469; PMCID: PMC6556082.
      Citations: 7     Fields:    Translation:Humans
    125. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019 06 04; 139(23):2642-2653. PMID: 31030544; PMCID: PMC6546524.
      Citations: 48     Fields:    Translation:HumansCells
    126. Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol. 2019 07 15; 124(2):296-302. PMID: 31104774.
      Citations:    Fields:    Translation:Humans
    127. Jia X, Akeroyd JM, Nasir K, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343. PMID: 30865483.
      Citations: 6     Fields:    Translation:Humans
    128. Virani SS, Akeroyd JM, Nambi V, Michos ED, Morris PB, Nasir K, Smith SC, Stone NJ, Petersen LA, Ballantyne CM. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412. PMID: 30586689.
      Citations: 3     Fields:    Translation:Humans
    129. Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 03; 282:52-56. PMID: 30685442; PMCID: PMC6699162.
      Citations: 13     Fields:    Translation:Humans
    130. Nambi V, Rohatgi A, Bhatt DL. Is RCT (Reverse Cholesterol Transport) Ready for an RCT (Randomized Controlled Trial)? J Am Coll Cardiol. 2018 12 25; 72(25):3270-3273. PMID: 30573029.
      Citations: 1     Fields:    Translation:Humans
    131. Saeed A, Virani SS, Ballantyne CM, Taylor AA, Nambi V. Are All Benefits and Harms Equal? J Am Coll Cardiol. 2018 08 14; 72(7):819-820. PMID: 30092962.
      Citations:    Fields:    Translation:Humans
    132. Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2018 07 10; 72(2):156-169. PMID: 29976289; PMCID: PMC6051722.
      Citations: 35     Fields:    Translation:Humans
    133. Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V. Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 06 19; 20(9):42. PMID: 29915890.
      Citations:    Fields:    
    134. Basra SS, Wang TY, Simon DN, Chiswell K, Peterson ED, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Jneid H. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12). PMID: 29886424; PMCID: PMC6220549.
      Citations: 5     Fields:    Translation:Humans
    135. Saeed A, Virani SS, Jones PH, Ballantyne CM, Nambi V. Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse. J Clin Lipidol. 2018 Sep - Oct; 12(5):1141-1145. PMID: 30318064.
      Citations: 2     Fields:    Translation:Humans
    136. Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V. Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 05 21; 20(7):35. PMID: 29781057.
      Citations: 6     Fields:    Translation:Humans
    137. McBride CL, Akeroyd JM, Ramsey DJ, Nambi V, Nasir K, Michos ED, Bush RL, Jneid H, Morris PB, Bittner VA, Ballantyne CM, Petersen LA, Virani SS. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240. PMID: 29600737.
      Citations: 15     Fields:    Translation:Humans
    138. Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults. J Am Coll Cardiol. 2018 06 05; 71(22):2527-2536. PMID: 29535064; PMCID: PMC5984171.
      Citations: 17     Fields:    Translation:Humans
    139. Faza NN, Virani SS, Nambi V, Shah T. Aberrant Course of Pacemaker Leads: When Left is Left. Tex Heart Inst J. 2018 02; 45(1):52-53. PMID: 29556156; PMCID: PMC5832091.
      Citations:    Fields:    Translation:Humans
    140. Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE. Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study. Circulation. 2018 05 15; 137(20):2142-2151. PMID: 29386202; PMCID: PMC6219377.
      Citations: 15     Fields:    Translation:Humans
    141. Nambi V, Deswal A, Ballantyne CM. Prevention of "Failure": Is It a Failure of Prevention? Circulation. 2018 01 09; 137(2):106-108. PMID: 29311345; PMCID: PMC5942594.
      Citations: 3     Fields:    Translation:Humans
    142. Nambi V, Bhatt DL. Primary Prevention of Atherosclerosis: Time to Take a Selfie? J Am Coll Cardiol. 2017 12 19; 70(24):2992-2994. PMID: 29241486.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    143. Ndumele CE, Cobb L, Lazo M, Bello NA, Shah A, Nambi V, Blumenthal RS, Gerstenblith G, Solomon SD, Ballantyne CM, Selvin E, Coresh J. Weight History and Subclinical Myocardial Damage. Clin Chem. 2018 01; 64(1):201-209. PMID: 29158254; PMCID: PMC6219376.
      Citations: 4     Fields:    Translation:Humans
    144. Saeed A, Kampangkaew J, Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 2017 Oct-Dec; 13(4):185-192. PMID: 29744010; PMCID: PMC5935277.
      Citations: 10     Fields:    Translation:Humans
    145. Kampangkaew J, Pickett S, Nambi V. Advances in the management of dyslipidemia. Curr Opin Cardiol. 2017 Jul; 32(4):348-355. PMID: 28505047.
      Citations:    Fields:    Translation:Humans
    146. Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CM. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137. PMID: 28554015; PMCID: PMC5523851.
      Citations: 10     Fields:    Translation:HumansCells
    147. Virani SS, Akeroyd JM, Nambi V, Heidenreich PA, Morris PB, Nasir K, Michos ED, Bittner VA, Petersen LA, Ballantyne CM. Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574. PMID: 28465286.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    148. Florido R, Ndumele CE, Kwak L, Pang Y, Matsushita K, Schrack JA, Lazo M, Nambi V, Blumenthal RS, Folsom AR, Coresh J, Ballantyne CM, Selvin E. Physical Activity, Obesity, and Subclinical?Myocardial Damage. JACC Heart Fail. 2017 05; 5(5):377-384. PMID: 28449797; PMCID: PMC5412715.
      Citations: 8     Fields:    Translation:Humans
    149. Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, Nasir K, Chan PS, Maddox TM, Oetgen WJ, Heidenreich PA, Borden WB, Spertus JA, Petersen LA, Ballantyne CM, Virani SS. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 04 01; 2(4):361-369. PMID: 28249067; PMCID: PMC5470413.
      Citations: 30     Fields:    Translation:Humans
    150. Saeed A, Virani SS, Jones PH, Nambi V, Ballantyne CM, Zoch D. A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience. J Clin Lipidol. 2017 May - Jun; 11(3):596-599. PMID: 28506382.
      Citations: 2     Fields:    Translation:Humans
    151. Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, Heiss G. Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study. BMJ Open Diabetes Res Care. 2017; 5(1):e000335. PMID: 28191321; PMCID: PMC5293824.
      Citations: 8     
    152. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani SS, Jneid H, Agarwal S, Chang PP, Loehr L, Basra SS, Rosamond W, Ballantyne CM, Deswal A. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66. PMID: 28185703; PMCID: PMC5368080.
      Citations: 12     Fields:    Translation:Humans
    153. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63. PMID: 28017350; PMCID: PMC5425302.
      Citations: 12     Fields:    Translation:Humans
    154. Johri AM, Herr JE, Li TY, Yau O, Nambi V. Novel Ultrasound Methods to Investigate Carotid Artery Plaque Vulnerability. J Am Soc Echocardiogr. 2017 02; 30(2):139-148. PMID: 27986358.
      Citations: 3     Fields:    Translation:Humans
    155. Pokharel Y, Sun W, Villareal DT, Selvin E, Virani SS, Ndumele CE, Hoogeveen RC, Coresh J, Boerwinkle E, Butler KR, Solomon SD, Pankow JS, Bozkurt B, Ballantyne CM, Nambi V. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638. PMID: 27941157; PMCID: PMC5405860.
      Citations: 6     Fields:    Translation:Humans
    156. Pokharel Y, Gosch K, Nambi V, Chan PS, Kosiborod M, Oetgen WJ, Spertus JA, Ballantyne CM, Petersen LA, Virani SS. Practice-Level Variation in?Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry. J Am Coll Cardiol. 2016 09 20; 68(12):1368-9. PMID: 27634128; PMCID: PMC5250510.
      Citations: 14     Fields:    Translation:Humans
    157. Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, Kee F, Salomaa V, Levy D, Kauhanen J, Laukkanen JA, Kavousi M, Ninomiya T, Casas JP, Daniels LB, Lind L, Kistorp CN, Rosenberg J, Mueller T, Rubattu S, Panagiotakos DB, Franco OH, de Lemos JA, Luchner A, Kizer JR, Kiechl S, Salonen JT, Goya Wannamethee S, de Boer RA, Andersson J, Melander O, Ballantyne ChM, DeFilippi Ch, Ridker PM, Cushman M, Rosamond WD, Thompson SG, Gudnason V, Sattar N, Danesh J, Di Angelantonio E, ?rnl?v J, Nordestgaard BG, J?rgensen T. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016 10; 4(10):840-9. PMID: 27599814; PMCID: PMC5035346.
      Citations: 59     Fields:    Translation:Humans
    158. Naqvi TZ, Nambi V. Risk Statins or Risk "Zero" on Atherosclerosis Imaging for Risk?Stratification? J Am Coll Cardiol. 2016 08 30; 68(9):892-4. PMID: 27561761.
      Citations:    Fields:    Translation:Humans
    159. Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016 10; 253:156-163. PMID: 27665201; PMCID: PMC5081270.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    160. Kamran H, Nambi V, Negi S, Yang EY, Chen C, Virani SS, Kougias P, Lumsden AB, Morrisett JD, Ballantyne CM, Brunner G. Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). Am J Cardiol. 2016 Nov 01; 118(9):1399-1404. PMID: 27670795; PMCID: PMC5179037.
      Citations: 2     Fields:    Translation:Humans
    161. McEvoy JW, Chen Y, Ndumele CE, Solomon SD, Nambi V, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death. JAMA Cardiol. 2016 08 01; 1(5):519-28. PMID: 27439107; PMCID: PMC5084093.
      Citations: 44     Fields:    Translation:Humans
    162. Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149. PMID: 27553104.
      Citations: 11     Fields:    Translation:Humans
    163. Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G, Nambi V, Ballantyne CM, Solomon SD, Selvin E, Folsom AR, Coresh J. Obesity and Subtypes of Incident Cardiovascular Disease. J Am Heart Assoc. 2016 07 28; 5(8). PMID: 27468925; PMCID: PMC5015307.
      Citations: 57     Fields:    Translation:Humans
    164. Pokharel Y, Akeroyd JM, Ramsey DJ, Hira RS, Nambi V, Shah T, Woodard LD, Winchester DE, Ballantyne CM, Petersen LA, Virani SS. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91. PMID: 27059708; PMCID: PMC4840034.
      Citations: 15     Fields:    Translation:Humans
    165. Rubin J, Matsushita K, Lazo M, Ballantyne CM, Nambi V, Hoogeveen R, Sharrett AR, Blumenthal RS, Coresh J, Selvin E. Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population. Clin Biochem. 2016 Jun; 49(9):657-662. PMID: 26975902; PMCID: PMC4889514.
      Citations: 10     Fields:    Translation:Humans
    166. Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Jones PH, Nambi V, Nasir K, Petersen L, Ballantyne CM, Virani SS. A dataset to assess providers? knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Data Brief. 2016 Jun; 7:595-8. PMID: 27054163; PMCID: PMC4802420.
      Citations: 1     
    167. Hoff J, Wehner W, Nambi V. Troponin in Cardiovascular Disease Prevention: Updates and Future Direction. Curr Atheroscler Rep. 2016 Mar; 18(3):12. PMID: 26879078.
      Citations: 10     Fields:    Translation:Humans
    168. Brunner G, Bismuth J, Nambi V, Ballantyne CM, Taylor AA, Lumsden AB, Morrisett JD, Shah DJ. Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease. Med Biol Eng Comput. 2016 Nov; 54(11):1667-1681. PMID: 26906279; PMCID: PMC5152942.
      Citations: 8     Fields:    Translation:Humans
    169. Crawford JR, Trial J, Nambi V, Hoogeveen RC, Taffet GE, Entman ML. Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease. J Cardiovasc Transl Res. 2016 06; 9(3):184-193. PMID: 26891844; PMCID: PMC4874871.
      Citations: 25     Fields:    Translation:HumansCells
    170. Ogunwale AN, Morrison AC, Sun W, Dodge RC, Virani SS, Taylor A, Gottesman RF, Yang E, Wei P, McEvoy JW, Heiss G, Boerwinkle E, Ballantyne CM, Nambi V. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36. PMID: 26869459; PMCID: PMC4981557.
      Citations: 1     Fields:    Translation:Humans
    171. Vu KN, Ballantyne CM, Hoogeveen RC, Nambi V, Volcik KA, Boerwinkle E, Morrison AC. Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One. 2016; 11(2):e0148765. PMID: 26849558; PMCID: PMC4744040.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    172. McRae MP, Bozkurt B, Ballantyne CM, Sanchez X, Christodoulides N, Simmons G, Nambi V, Misra A, Miller CS, Ebersole JL, Campbell C, McDevitt JT. Cardiac ScoreCard: A Diagnostic Multivariate Index Assay System for Predicting a Spectrum of Cardiovascular Disease. Expert Syst Appl. 2016 Jul 15; 54:136-147. PMID: 31467464; PMCID: PMC6715313.
      Citations: 3     
    173. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8. PMID: 26746175; PMCID: PMC4758863.
      Citations: 36     Fields:    Translation:Humans
    174. Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Jones PH, Nambi V, Nasir K, Petersen L, Ballantyne CM, Virani SS. Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20. PMID: 26773472; PMCID: PMC5723424.
      Citations: 9     Fields:    Translation:Humans
    175. Kumar A, Yang EY, Brunner G, Murray TO, Virani SS, Garami Z, Ballantyne CM, Morrisett JD, Nambi V. Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. JACC Cardiovasc Imaging. 2016 09; 9(9):1118-1119. PMID: 26684968.
      Citations:    Fields:    Translation:Humans
    176. Virani SS, Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Gowani SA, Kalra A, Polsani V, Miedema MD, Jones PH, Nambi V, Petersen LA, Ballantyne CM. Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016 May-Jun; 10(3):497-504.e4. PMID: 27206936.
      Citations: 30     Fields:    Translation:Humans
    177. Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. Clin Chem. 2015 Dec; 61(12):1524-31. PMID: 26506994.
      Citations: 15     Fields:    Translation:Humans
    178. Sharafkhaneh A, Katigbak J, Hirshkowitz M, Sharafkhaneh H, Sharafkhaneh SP, Ballantyne CM, Bozkurt B, Nambi V. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015 Oct 16; 16:126. PMID: 26475736; PMCID: PMC4609126.
      Citations: 2     Fields:    Translation:HumansCells
    179. McEvoy JW, Chen Y, Nambi V, Ballantyne CM, Sharrett AR, Appel LJ, Post WS, Blumenthal RS, Matsushita K, Selvin E. High-Sensitivity Cardiac Troponin T and Risk of Hypertension. Circulation. 2015 Sep 01; 132(9):825-33. PMID: 26152706; PMCID: PMC4558242.
      Citations: 36     Fields:    Translation:Humans
    180. Virani SS, Akeroyd JM, Nambi V, Maddox TM, Gillette MA, Michael Ho P, Rumsfeld J, Petersen LA, Ballantyne CM. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6. PMID: 26071828.
      Citations: 2     Fields:    Translation:Humans
    181. Murray T, Yang EY, Brunner G, Kumar A, Lakkis N, Misra A, Virani SS, Hartley CJ, Morrisett JD, Ballantyne CM, Nambi V. Postprandial effects on arterial stiffness parameters in healthy young adults. Vasc Med. 2015 Dec; 20(6):501-8. PMID: 26060082.
      Citations: 3     Fields:    Translation:Humans
    182. McEvoy JW, Lazo M, Chen Y, Shen L, Nambi V, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study. Int J Cardiol. 2015; 187:651-7. PMID: 25880403; PMCID: PMC4442046.
      Citations: 17     Fields:    Translation:Humans
    183. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21. PMID: 25593051.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    184. Agarwala A, Jones P, Nambi V. The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations. Curr Atheroscler Rep. 2015 Jan; 17(1):467. PMID: 25398643.
      Citations: 9     Fields:    Translation:Humans
    185. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9. PMID: 25541126; PMCID: PMC4280076.
      Citations: 23     Fields:    Translation:Humans
    186. Pokharel Y, Sun W, de Lemos JA, Taffet GE, Virani SS, Ndumele CE, Mosley TH, Hoogeveen RC, Coresh J, Wright JD, Heiss G, Boerwinkle EA, Bozkurt B, Solomon SD, Ballantyne CM, Nambi V. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84. PMID: 25350984; PMCID: PMC4268376.
      Citations: 15     Fields:    Translation:Humans
    187. Ndumele CE, Coresh J, Lazo M, Hoogeveen RC, Blumenthal RS, Folsom AR, Selvin E, Ballantyne CM, Nambi V. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail. 2014 Dec; 2(6):600-7. PMID: 25443112; PMCID: PMC4345168.
      Citations: 33     Fields:    Translation:Humans
    188. Filion KB, Agarwal SK, Ballantyne CM, Eberg M, Hoogeveen RC, Huxley RR, Loehr LR, Nambi V, Soliman EZ, Alonso A. High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2015 Jan; 169(1):31-8.e3. PMID: 25497245; PMCID: PMC4429290.
      Citations: 20     Fields:    Translation:Humans
    189. Pokharel Y, Basra S, Lincoln AE, Tucker AM, Nambi V, Nasir K, Vogel RA, Wong ND, Boone JL, Roberts AJ, Ballantyne CM, Virani SS. Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players. South Med J. 2014 Oct; 107(10):633-9. PMID: 25279867.
      Citations: 10     Fields:    Translation:Humans
    190. Basra SS, Pokharel Y, Hira RS, Bandeali SJ, Nambi V, Deswal A, Nasir K, Martin SS, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40. PMID: 25432152.
      Citations: 7     Fields:    Translation:Humans
    191. Ababneh B, Rejjal L, Pokharel Y, Nambi V, Wang X, Tung CH, Han RI, Taylor AA, Kougias P, Lumsden AB, Lawrie G, Reardon M, Ballantyne CM, Morrisett JD, Brunner G. Distribution of calcification in carotid endarterectomy tissues: comparison of micro-computed tomography imaging with histology. Vasc Med. 2014 Oct; 19(5):343-50. PMID: 25193489.
      Citations: 3     Fields:    Translation:Humans
    192. Gupta DK, Skali H, Claggett B, Kasabov R, Cheng S, Shah AM, Loehr LR, Heiss G, Nambi V, Aguilar D, Wruck LM, Matsushita K, Folsom AR, Rosamond WD, Solomon SD. Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail. 2014 Oct; 2(5):447-54. PMID: 25194293; PMCID: PMC4194157.
      Citations: 16     Fields:    Translation:Humans
    193. Pokharel Y, Nambi V, Martin SS, Hoogeveen RC, Nasir K, Khera A, Wong ND, Jones PH, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct; 236(2):251-6. PMID: 25105582.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    194. Hira RS, Kennedy K, Jneid H, Alam M, Basra SS, Petersen LA, Ballantyne CM, Nambi V, Chan PS, Virani SS. Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7. PMID: 24814485.
      Citations: 18     Fields:    Translation:Humans
    195. Pokharel Y, Macedo FY, Nambi V, Martin SS, Nasir K, Wong ND, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014 Jul; 37(7):402-7. PMID: 24648005; PMCID: PMC6649371.
      Citations: 5     Fields:    Translation:Humans
    196. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014 Apr 15; 63(14):1441-8. PMID: 24530665; PMCID: PMC3984900.
      Citations: 85     Fields:    Translation:Humans
    197. Folsom AR, Lutsey PL, Nambi V, deFilippi CR, Heckbert SR, Cushman M, Ballantyne CM. Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med. 2014 Feb; 19(1):33-41. PMID: 24558027; PMCID: PMC4006375.
      Citations: 10     Fields:    Translation:Humans
    198. Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE, VISTA-16 Investigators. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014 Jan 15; 311(3):252-62. PMID: 24247616.
      Citations: 93     Fields:    Translation:Humans
    199. Brunner G, Yang EY, Kumar A, Sun W, Virani SS, Negi SI, Murray T, Lin PH, Hoogeveen RC, Chen C, Dong JF, Kougias P, Taylor A, Lumsden AB, Nambi V, Ballantyne CM, Morrisett JD. The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec; 231(2):371-7. PMID: 24267254; PMCID: PMC4545656.
      Citations: 10     Fields:    Translation:Humans
    200. Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study. Vasc Med. 2013 Oct; 18(5):245-50. PMID: 24165467; PMCID: PMC3980470.
      Citations: 9     Fields:    Translation:Humans
    201. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10. PMID: 24036936; PMCID: PMC4208068.
      Citations: 46     Fields:    Translation:Humans
    202. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92. PMID: 23891427; PMCID: PMC3800478.
      Citations:    Fields:    Translation:Humans
    203. Dadu RT, Dodge R, Nambi V, Virani SS, Hoogeveen RC, Smith NL, Chen F, Pankow JS, Guild C, Tang WH, Boerwinkle E, Hazen SL, Ballantyne CM. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43. PMID: 23861484; PMCID: PMC3908901.
      Citations: 22     Fields:    Translation:HumansCells
    204. Yang EY, Brunner G, Dokainish H, Hartley CJ, Taffet G, Lakkis N, Taylor AA, Misra A, McCulloch ML, Morrisett JD, Virani SS, Ballantyne CM, Nagueh SF, Nambi V. Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr. 2013 Aug; 26(8):901-909.e1. PMID: 23759168; PMCID: PMC3725197.
      Citations: 6     Fields:    Translation:Humans
    205. Wooten JS, Nambi P, Gillard BK, Pownall HJ, Coraza I, Scott LW, Nambi V, Ballantyne CM, Balasubramanyam A. Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients. Med Sci Sports Exerc. 2013 Jun; 45(6):1043-50. PMID: 23299761; PMCID: PMC3655089.
      Citations: 8     Fields:    Translation:HumansCells
    206. Dadu RT, Fornage M, Virani SS, Nambi V, Hoogeveen RC, Boerwinkle E, Alonso A, Gottesman RF, Mosley TH, Ballantyne CM. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013 Jul; 44(7):1803-8. PMID: 23660848; PMCID: PMC4334904.
      Citations: 26     Fields:    Translation:Humans
    207. Nambi V, Brunner G, Ballantyne CM. Ultrasound in cardiovascular risk prediction: don't forget the plaque! J Am Heart Assoc. 2013 Apr 18; 2(2):e000180. PMID: 23598274; PMCID: PMC3647285.
      Citations: 8     Fields:    Translation:Humans
    208. Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, Huxley RR, Ballantyne CM. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013 Apr; 44(4):961-7. PMID: 23471272; PMCID: PMC3614093.
      Citations: 72     Fields:    Translation:Humans
    209. Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, deFilippi CR, O'Donnell CJ, Kathiresan S, Rice K, Heckbert SR, Ballantyne CM, Psaty BM, Boerwinkle E, CARDIoGRAM Consortium. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circ Cardiovasc Genet. 2013 Feb; 6(1):82-8. PMID: 23247143; PMCID: PMC3693561.
      Citations: 15     Fields:    Translation:Humans
    210. Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM, ARIC Study Investigators. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol. 2013 Feb; 23(2):66-73. PMID: 23228375; PMCID: PMC3543509.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    211. Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, de Lemos JA, Omland T. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol. 2013 Jan 15; 61(2):187-95. PMID: 23219305; PMCID: PMC3547631.
      Citations: 43     Fields:    Translation:Humans
    212. Kayani WT, Bandeali SJ, Lee VV, Elayda M, Khan A, Nambi V, Jneid H, Alam M, Wilson JM, Huang HD, Birnbaum Y, Ballantyne CM, Virani SS. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20. PMID: 23046597.
      Citations: 7     Fields:    Translation:Humans
    213. Rubin J, Nambi V, Chambless LE, Steffes MW, Juraschek SP, Coresh J, Sharrett AR, Selvin E. Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study. Atherosclerosis. 2012 Nov; 225(1):246-51. PMID: 23031361; PMCID: PMC3936879.
      Citations: 14     Fields:    Translation:Humans
    214. Folsom AR, Nambi V, Pankow JS, Tang W, Farbakhsh K, Yamagishi K, Boerwinkle E. Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 Oct; 224(2):435-9. PMID: 22935634; PMCID: PMC3459136.
      Citations: 4     Fields:    Translation:HumansCells
    215. Bandeali SJ, Kayani WT, Lee VV, Pan W, Elayda MA, Nambi V, Jneid HM, Alam M, Wilson JM, Birnbaum Y, Ballantyne CM, Virani SS. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23. PMID: 22727178.
      Citations: 8     Fields:    Translation:Humans
    216. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, Rivadeneira F, Hofman A, Witteman JC, Pencina MJ, Folsom AR, Cupples LA, Ballantyne CM, Boerwinkle E, Uitterlinden AG. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug; 223(2):421-6. PMID: 22789513; PMCID: PMC3595115.
      Citations: 36     Fields:    Translation:Humans
    217. Nambi V, Pedroza C, Kao LS. Carotid intima-media thickness and cardiovascular events. Lancet. 2012 Jun 02; 379(9831):2028-30. PMID: 22541276.
      Citations: 7     Fields:    Translation:Humans
    218. Virani SS, Pompeii L, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Boone JL, Roberts AJ, Ballantyne CM. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6. PMID: 22525822.
      Citations: 9     Fields:    Translation:Humans
    219. Negi SI, Nambi V. The role of carotid intimal thickness and plaque imaging in risk stratification for coronary heart disease. Curr Atheroscler Rep. 2012 Apr; 14(2):115-23. PMID: 22281656.
      Citations: 9     Fields:    Translation:Humans
    220. Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6. PMID: 22322877; PMCID: PMC3837386.
      Citations: 19     Fields:    Translation:HumansCells
    221. Nambi V, Boerwinkle E, Lawson K, Brautbar A, Chambless L, Franeschini N, North KE, Virani SS, Folsom AR, Ballantyne CM. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May; 222(1):135-7. PMID: 22349088; PMCID: PMC3334435.
      Citations: 6     Fields:    Translation:HumansCells
    222. Wassel CL, Lamina C, Nambi V, Coassin S, Mukamal KJ, Ganesh SK, Jacobs DR, Franceschini N, Papanicolaou GJ, Gibson Q, Yanek LR, van der Harst P, Ferguson JF, Crawford DC, Waite LL, Allison MA, Criqui MH, McDermott MM, Mehra R, Cupples LA, Hwang SJ, Redline S, Kaplan RC, Heiss G, Rotter JI, Boerwinkle E, Taylor HA, Eraso LH, Haun M, Li M, Meisinger C, O'Connell JR, Shuldiner AR, Frikke-Schmidt R, Kollerits B, Rantner B, Dieplinger B, Stadler M, Mueller T, Haltmayer M, Klein-Weigel P, Summerer M, Wichmann HE, Asselbergs FW, Navis G, Mateo Leach I, Brown-Gentry K, Goodloe R, Assimes TL, Becker DM, Cooke JP, Absher DM, Olin JW, Mitchell BD, Reilly MP, Mohler ER, North KE, Reiner AP, Kronenberg F, Murabito JM, Tybj?rg-Hansen A. Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis. 2012 May; 222(1):138-47. PMID: 22361517; PMCID: PMC3596171.
      Citations: 11     Fields:    Translation:Humans
    223. Dadu RT, Nambi V, Ballantyne CM. Developing and assessing cardiovascular biomarkers. Transl Res. 2012 Apr; 159(4):265-76. PMID: 22424430.
      Citations: 10     Fields:    Translation:Humans
    224. Brautbar A, Virani SS, Belmont J, Nambi V, Jones PH, Ballantyne CM. LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. J Lipid Res. 2012 Mar; 53(3):556-560. PMID: 22236405; PMCID: PMC3276479.
      Citations: 8     Fields:    Translation:Humans
    225. Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W, Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol. 2013 Jul 15; 167(1):180-4. PMID: 22240765.
      Citations: 13     Fields:    Translation:Humans
    226. Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, Lamina C, Schillert A, Coassin S, Bis JC, Broer L, Crawford DC, Franceschini N, Frikke-Schmidt R, Haun M, Holewijn S, Huffman JE, Hwang SJ, Kiechl S, Kollerits B, Montasser ME, Nolte IM, Rudock ME, Senft A, Teumer A, van der Harst P, Vitart V, Waite LL, Wood AR, Wassel CL, Absher DM, Allison MA, Amin N, Arnold A, Asselbergs FW, Aulchenko Y, Bandinelli S, Barbalic M, Boban M, Brown-Gentry K, Couper DJ, Criqui MH, Dehghan A, den Heijer M, Dieplinger B, Ding J, Espinola-Klein C, Felix SB, Ferrucci L, Folsom AR, Fraedrich G, Gibson Q, Goodloe R, Gunjaca G, Haltmayer M, Heiss G, Hofman A, Kieback A, Kiemeney LA, Kolcic I, Kullo IJ, Kritchevsky SB, Lackner KJ, Li X, Lieb W, Lohman K, Meisinger C, Melzer D, Mohler ER, Mudnic I, Mueller T, Navis G, Oberhollenzer F, Olin JW, O'Connell J, O'Donnell CJ, Palmas W, Penninx BW, Petersmann A, Polasek O, Psaty BM, Rantner B, Rice K, Rivadeneira F, Rotter JI, Seldenrijk A, Stadler M, Summerer M, Tanaka T, Tybjaerg-Hansen A, Uitterlinden AG, van Gilst WH, Vermeulen SH, Wild SH, Wild PS, Willeit J, Zeller T, Zemunik T, Zgaga L, Assimes TL, Blankenberg S, Boerwinkle E, Campbell H, Cooke JP, de Graaf J, Herrington D, Kardia SL, Mitchell BD, Murray A, Newman AB, Oostra BA, Rudan I, Shuldiner AR, Snieder H, van Duijn CM, Wright AF, Wichmann HE, Wilson JF, Witteman JC, Liu Y, Hayward C, Borecki IB, Ziegler A, North KE, Cupples LA, Kronenberg F, D?rr M, M?nzel T, V?lker U. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet. 2012 Feb 01; 5(1):100-12. PMID: 22199011; PMCID: PMC3303225.
      Citations: 52     Fields:    Translation:HumansCells
    227. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012 Jan 17; 125(2):241-9. PMID: 22128224; PMCID: PMC3760720.
      Citations: 83     Fields:    Translation:Humans
    228. Negi SI, Steinberg L, Polsani VR, Gowani SA, Nambi V, Kumar V, Marinescu V, Jones PH, Petersen LA, Ballantyne CM, Virani SS. Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. J Clin Lipidol. 2012 Jan-Feb; 6(1):50-7. PMID: 22264574.
      Citations: 5     Fields:    Translation:Humans
    229. Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, Boerwinkle E, Ballantyne CM, Nambi V. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan; 43(1):103-8. PMID: 22033999; PMCID: PMC3246524.
      Citations: 50     Fields:    Translation:Humans
    230. Yang EY, Nambi V. Ultrasound imaging of carotid intima-media thickness: an office-based tool to assist physicians in cardiovascular risk assessment. Curr Atheroscler Rep. 2011 Oct; 13(5):431-6. PMID: 21814753.
      Citations: 2     Fields:    Translation:Humans
    231. Bis JC, Kavousi M, Franceschini N, Isaacs A, Schminke U, Post WS, Smith AV, Cupples LA, Markus HS, Schmidt R, Huffman JE, Baumert J, Heckbert SR, Dehghan A, North K, Oostra B, Bevan S, Stoegerer EM, Hayward C, Raitakari O, Meisinger C, Schillert A, Sanna S, Cheng YC, Thorsson B, Fox CS, Rice K, Rivadeneira F, Nambi V, Halperin E, Petrovic KE, Peltonen L, Wichmann HE, Schnabel RB, Parsa A, Aspelund T, Demissie S, Kathiresan S, Reilly MP, Taylor K, Uitterlinden A, Couper DJ, Sitzer M, Illig T, Wild PS, Orru M, Shuldiner AR, Eiriksdottir G, White CC, Rotter JI, Hofman A, Seissler J, Zeller T, Usala G, Ernst F, Launer LJ, D'Agostino RB, O'Leary DH, Ballantyne C, Thiery J, Ziegler A, Lakatta EG, Chilukoti RK, Harris TB, Wolf PA, Psaty BM, Polak JF, Li X, Rathmann W, Uda M, Boerwinkle E, Klopp N, Schmidt H, Wilson JF, Viikari J, Koenig W, Blankenberg S, Newman AB, Witteman J, Heiss G, Duijn Cv, Scuteri A, Homuth G, Mitchell BD, Gudnason V, O'Donnell CJ, CARDIoGRAM Consortium, Abecasis GR, Lehtim?ki T, M?nzel T, V?lzke H, D?rr M, K?h?nen M, L?demann J. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011 Sep 11; 43(10):940-7. PMID: 21909108; PMCID: PMC3257519.
      Citations: 113     Fields:    Translation:Humans
    232. Yang EY, Dokainish H, Virani SS, Misra A, Pritchett AM, Lakkis N, Brunner G, Bobek J, McCulloch ML, Hartley CJ, Ballantyne CM, Nagueh SF, Nambi V. Segmental analysis of carotid arterial strain using speckle-tracking. J Am Soc Echocardiogr. 2011 Nov; 24(11):1276-1284.e5. PMID: 21907541; PMCID: PMC3200442.
      Citations: 11     Fields:    Translation:Humans
    233. Virani SS, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozkurt B, Petersen LA, Ballantyne CM. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2. PMID: 21854896; PMCID: PMC4180871.
      Citations: 10     Fields:    Translation:Humans
    234. Brunner G, Nambi V, Yang E, Kumar A, Virani SS, Kougias P, Shah D, Lumsden A, Ballantyne CM, Morrisett JD. Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magn Reson Imaging. 2011 Oct; 29(8):1065-75. PMID: 21855242.
      Citations: 14     Fields:    Translation:Humans
    235. Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602. PMID: 21868017; PMCID: PMC3226845.
      Citations: 15     Fields:    Translation:Humans
    236. Nambi V. Carotid intima media thickness. J Am Soc Echocardiogr. 2011 Aug; 24(8):A25. PMID: 21791274.
      Citations:    Fields:    Translation:Humans
    237. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, Ballantyne CM. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J. 2012 Jan; 33(2):183-90. PMID: 21666250; PMCID: PMC3258447.
      Citations: 58     Fields:    Translation:Humans
    238. Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, Sharrett AR, Coresh J, Heiss G, Hoogeveen RC. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem. 2011 Jun; 57(6):891-7. PMID: 21519038; PMCID: PMC4928588.
      Citations: 42     Fields:    Translation:Humans
    239. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, Jneid HM, Wilson JM, Ballantyne CM, Virani SS. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85. PMID: 21498907.
      Citations: 5     Fields:    Translation:Humans
    240. Yang EY, Polsani VR, Washburn MJ, Zang W, Hall AL, Virani SS, Hodge MD, Parker D, Kerwin WS, Lawrie GM, Garami Z, Ballantyne CM, Morrisett JD, Nambi V. Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr. 2011 Jul; 24(7):720-8. PMID: 21439782; PMCID: PMC3123396.
      Citations: 3     Fields:    Translation:Humans
    241. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 05; 123(13):1367-76. PMID: 21422391; PMCID: PMC3072024.
      Citations: 273     Fields:    Translation:Humans
    242. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2011 May 15; 107(10):1504-9. PMID: 21414601; PMCID: PMC3087849.
      Citations: 18     Fields:    Translation:HumansCells
    243. Dehghan A, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, Baumert J, Strachan DP, Fuchsberger C, Vitart V, Wilson JF, Naitza S, Rudock ME, Surakka I, de Geus EJ, Alizadeh BZ, Guralnik J, Shuldiner A, Tanaka T, Zee RY, Schnabel RB, Nambi V, Kavousi M, Ripatti S, Nauck M, Smith NL, Smith AV, Sundvall J, Scheet P, Liu Y, Ruokonen A, Rose LM, Larson MG, Hoogeveen RC, Freimer NB, Teumer A, Tracy RP, Launer LJ, Buring JE, Yamamoto JF, Folsom AR, Sijbrands EJ, Pankow J, Elliott P, Keaney JF, Sun W, Sarin AP, Badola S, Astor BC, Hofman A, Pouta A, Werdan K, Greiser KH, Kuss O, Meyer zu Schwabedissen HE, Thiery J, Jamshidi Y, Nolte IM, Soranzo N, Spector TD, Parker AN, Aspelund T, Bates D, Young L, Tsui K, Siscovick DS, Guo X, Rotter JI, Uda M, Schlessinger D, Rudan I, Hicks AA, Penninx BW, Thorand B, Gieger C, Coresh J, Willemsen G, Harris TB, Uitterlinden AG, Rice K, Salomaa V, Willems van Dijk K, Boerwinkle E, Vasan RS, Ferrucci L, Gibson QD, Bandinelli S, Snieder H, Boomsma DI, Xiao X, Campbell H, Hayward C, Pramstaller PP, van Duijn CM, Peltonen L, Psaty BM, Gudnason V, Ridker PM, Homuth G, Koenig W, Ballantyne CM, Witteman JC, Benjamin EJ, Perola M, Chasman DI, Dupuis J, Par? G, Fontes JD, V?lzke H, J?rvelin MR, Radke D. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011 Feb 22; 123(7):731-8. PMID: 21300955; PMCID: PMC3147232.
      Citations: 255     Fields:    Translation:Humans
    244. Saunders J, Nambi V, Kimball KT, Virani SS, Morrisett JD, Lumsden AB, Ballantyne CM, Dong JF, ELIMIT Investigators. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. J Vasc Surg. 2011 Mar; 53(3):668-75. PMID: 21227624; PMCID: PMC3197816.
      Citations: 5     Fields:    Translation:Humans
    245. Nambi V, Feinstein SB, Coll B. New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum. Curr Cardiol Rep. 2010 Nov; 12(6):497-502. PMID: 20799001.
      Citations: 4     Fields:    Translation:Humans
    246. Negi S, Nambi V. Coronary heart disease risk stratification: pitfalls and possibilities. Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan; 6(4):26-32. PMID: 21088656.
      Citations:    Fields:    Translation:Humans
    247. Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, Gonzalez F, Chambless LE, Mosley TH, Boerwinkle E, Ballantyne CM. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011 Feb; 32(4):459-68. PMID: 20943669; PMCID: PMC3106284.
      Citations: 25     Fields:    Translation:Humans
    248. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010 Apr 13; 55(15):1600-7. PMID: 20378078; PMCID: PMC2862308.
      Citations: 269     Fields:    Translation:Humans
    249. Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6. PMID: 20398096.
      Citations: 14     Fields:    Translation:Humans
    250. Barbalic M, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, Lu C, Tracy RP, Aleksic N, Heeriga J, Keaney JF, Rice K, Lip GY, Vasan RS, Glazer NL, Larson MG, Uitterlinden AG, Yamamoto J, Durda P, Haritunians T, Psaty BM, Boerwinkle E, Hofman A, Koenig W, Jenny NS, Witteman JC, Ballantyne C, Benjamin EJ, Dupuis J. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010 May 01; 19(9):1863-72. PMID: 20167578; PMCID: PMC2850624.
      Citations: 111     Fields:    Translation:HumansCells
    251. Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Coresh J, Chambless L, Ballantyne CM. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15; 54(25):2388-95. PMID: 20082929; PMCID: PMC2829945.
      Citations: 11     Fields:    Translation:Humans
    252. Nambi V. Vascular and cardiac ultrasonographers: is it time to use frequencies from the same band-width? J Am Soc Echocardiogr. 2009 Nov; 22(11):A30. PMID: 19883871.
      Citations:    Fields:    Translation:Humans
    253. Polsani VR, Nambi V, Virani SS, Yang EY, Jones PH, Ballantyne CM, Zoch D. Efficacy and tolerability of multidrug therapy for hypertriglyceridemia. J Clin Lipidol. 2009 Oct; 3(5):341-4. PMID: 21291832.
      Citations:    Fields:    
    254. Shiffman D, Chasman DI, Ballantyne CM, Nambi V, Devlin JJ, Boerwinkle E. Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost. 2009 Jul; 102(1):179-80. PMID: 19572086; PMCID: PMC4351745.
      Citations: 2     Fields:    Translation:Humans
    255. Nambi V, Kimball KT, Bray PF, Bergeron AL, Johnson SL, Morrisett JD, Chen C, Lin PH, Lumsden AB, Ballantyne CM, Dong JF. Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). Platelets. 2009 May; 20(3):199-205. PMID: 19437338; PMCID: PMC2869211.
      Citations: 5     Fields:    Translation:Humans
    256. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet. 2009 Jun; 2(3):279-85. PMID: 20031596; PMCID: PMC2771929.
      Citations: 44     Fields:    Translation:HumansCells
    257. Polsani VR, Virani SS, Nambi V. Lipid management: considerations in acute coronary syndrome. Curr Atheroscler Rep. 2009 Mar; 11(2):149-56. PMID: 19228490.
      Citations:    Fields:    
    258. Nambi V. Inflammation and cardiovascular risk. Vijay Nambi speaks to Christine Forder, commissioning editor. Future Cardiol. 2009 Mar; 5(2):121-3. PMID: 19371186.
      Citations:    Fields:    Translation:HumansPHPublic Health
    259. Nambi V, Ballantyne CM. "Risky business": ten years is not a lifetime. Circulation. 2009 Jan 27; 119(3):362-4. PMID: 19171864.
      Citations: 4     Fields:    Translation:Humans
    260. Virani SS, Nambi V, Lee VV, Elayda MA, Pan W, Petersen LA, Wilson JM, Willerson JT, Ballantyne CM. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5. PMID: 20069078; PMCID: PMC2801932.
      Citations: 4     Fields:    Translation:Humans
    261. Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, Ni H, Boerwinkle E, Mosley T, Sharrett R, Folsom AR, Ballantyne CM. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009 Feb; 40(2):376-81. PMID: 19095974; PMCID: PMC2711777.
      Citations: 19     Fields:    Translation:Humans
    262. Virani SS, Nambi V, Lee VV, Elayda M, Reul RM, Wilson JM, Ballantyne CM. Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery? Am J Cardiol. 2008 Nov 01; 102(9):1235-9. PMID: 18940299.
      Citations: 6     Fields:    Translation:Humans
    263. Polsani VR, Virani SS, Nambi V. Lipid management: considerations in acute coronary syndrome. Curr Cardiol Rep. 2008 Jul; 10(4):334-41. PMID: 18611369.
      Citations:    Fields:    Translation:Humans
    264. Virani SS, Polsani VR, Nambi V. Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep. 2008 Apr; 10(2):164-70. PMID: 18417072.
      Citations: 10     Fields:    Translation:Humans
    265. Polsani VR, Jones PH, Ballantyne CM, Nambi V. A case report of myopathy from consumption of red yeast rice. J Clin Lipidol. 2008 Feb; 2(1):60-2. PMID: 21291717.
      Citations: 8     Fields:    
    266. Baez-Escudero J, Pillai M, Nambi V, Dokainish H. Comprehensive contrast and 3-dimensional echocardiographic imaging of left ventricular noncompaction cardiomyopathy. Eur J Echocardiogr. 2008 Jan; 9(1):156-7. PMID: 17602876.
      Citations: 2     Fields:    Translation:Humans
    267. Nambi V, Morrison AC, Hoogeveen RC, Coresh J, Miles S, Rhodes CE, Sharrett AR, Boerwinkle BE, Ballantyne CM. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. Tex Heart Inst J. 2008; 35(4):388-94. PMID: 19156230; PMCID: PMC2607088.
      Citations: 5     Fields:    Translation:Humans
    268. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008 Mar; 155(3):541-6. PMID: 18294494.
      Citations: 16     Fields:    Translation:Humans
    269. Virani SS, Nambi V. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep. 2007 Aug; 9(2):97-103. PMID: 17877917.
      Citations: 4     Fields:    Translation:Humans
    270. Lumsden AB, Rice TW, Chen C, Zhou W, Lin PH, Bray P, Morrisett J, Nambi V, Ballantyne C. Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World J Surg. 2007 Apr; 31(4):695-704. PMID: 17345122.
      Citations: 12     Fields:    Translation:Humans
    271. Nambi V, Ballantyne CM. Role of biomarkers in developing new therapies for vascular disease. World J Surg. 2007 Apr; 31(4):676-81. PMID: 17387551.
      Citations: 1     Fields:    Translation:Humans
    272. Nambi V, Ballantyne CM. Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events. Curr Atheroscler Rep. 2006 Sep; 8(5):374-81. PMID: 16901407.
      Citations: 4     Fields:    Translation:Humans
    273. Nambi V, Ballantyne CM. Combination therapy with statins and omega-3 fatty acids. Am J Cardiol. 2006 Aug 21; 98(4A):34i-38i. PMID: 16919515.
      Citations: 10     Fields:    Translation:Humans
    274. Nambi V, Ballantyne CM. Fat, fit, and leading the charge: the evolution of measuring high-density lipoprotein subpopulations. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2013-5. PMID: 16199755.
      Citations: 1     Fields:    Translation:Humans
    275. Hartley WB, Nambi V, Plana JC, Shah G, Zoghbi WA. Dyspnea in a patient with a prosthetic mitral valve. J Am Coll Cardiol. 2005 Sep 06; 46(5):CS2-4. PMID: 16237867.
      Citations:    Fields:    Translation:Humans
    276. Nambi V, Buergler JM, Lakkis NM, Franklin J, Spencer WH, Nagueh SF. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1. PMID: 16098315.
      Citations:    Fields:    Translation:Humans
    277. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl. 2005 May; 6(2):21-9. PMID: 15823493.
      Citations: 41     Fields:    Translation:Humans
    278. Nambi V. The use of myeloperoxidase as a risk marker for atherosclerosis. Curr Atheroscler Rep. 2005 Mar; 7(2):127-31. PMID: 15727728.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    279. Nambi V, Ballantyne CM. Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk. Curr Atheroscler Rep. 2005 Feb; 7(1):22-8. PMID: 15683598.
      Citations: 3     Fields:    Translation:Humans
    280. Marian AJ, Nambi V. Biomarkers of cardiac disease. Expert Rev Mol Diagn. 2004 Nov; 4(6):805-20. PMID: 15525223.
      Citations: 3     Fields:    Translation:Humans
    281. Ballantyne CM, Nambi V. Apolipoprotein A-I and high-density lipoprotein: is this the beginning of the era of noninvasive angioplasty? J Am Coll Cardiol. 2004 Oct 06; 44(7):1436-8. PMID: 15464324.
      Citations: 2     Fields:    Translation:Humans
    282. Nambi V, Ballantyne CM. ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients. Curr Atheroscler Rep. 2004 Sep; 6(5):353-8. PMID: 15296701.
      Citations:    Fields:    Translation:Humans
    283. Nambi V, Gomes MP, Deitcher SR. Goal-oriented thrombolytic therapy for venous thromboembolic disease. Clin Adv Hematol Oncol. 2004 Mar; 2(3):169-72. PMID: 16166947.
      Citations:    Fields:    Translation:Humans
    284. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003 Oct 23; 349(17):1595-604. PMID: 14573731.
      Citations: 247     Fields:    Translation:Humans
    285. Kalahasti V, Nambi V, Martin DO, Lam CT, Yamada D, Wilkoff BL, Niebauer MJ, Jaeger FJ, Tchou PJ, Chung MK. QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. Am J Cardiol. 2003 Oct 01; 92(7):798-803. PMID: 14516879.
      Citations: 18     Fields:    Translation:Humans
    286. Frolkis JP, Pearce GL, Nambi V, Minor S, Sprecher DL. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med. 2002 Dec 01; 113(8):625-9. PMID: 12505111.
      Citations: 20     Fields:    Translation:Humans
    287. Nambi V, Hoogwerf BJ, Sprecher DL. A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clin J Med. 2002 Dec; 69(12):985-9. PMID: 12546271.
      Citations: 3     Fields:    Translation:Humans
    NAMBI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (598)
    Explore
    _
    Co-Authors (65)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _